Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Magenta Therapeutics, Inc. (MGTA)
|
Add to portfolio |
|
|
|
| Price: |
$4.77
| | Metrics |
| OS: |
60.7
|
M
| |
|
|
| Market cap: |
$289
|
M
| |
|
|
|
Net cash:
|
$77.6
|
M
| |
$1.28
|
per share
|
|
EV:
|
$212
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 55.1 | 46.8 | 50.6 | 59.2 | 41.3 | 27.9 | 5.8 |
| General and administrative | 25.8 | 27.9 | 28.1 | 23.8 | 18.6 | 7.8 | 3.5 |
| EBIT | -80.9 | -74.7 | -78.7 | -83.0 | -60.0 | -35.7 | -9.3 |
| Pre-tax income | -76.5 | -71.1 | -74.9 | -76.8 | -57.5 | -35.5 | -9.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -76.5 | -71.1 | -74.9 | -76.8 | -57.6 | -35.5 | -9.7 |
| |
| Diluted EPS | ($1.29) | ($1.29) | ($1.71) | ($2.07) | ($3.13) | ($19.12) | ($65.15) |
| Shares outstanding (diluted) | 59.4 | 54.9 | 43.9 | 37.0 | 18.4 | 1.9 | 0.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|